Kontos, Christos
El Bounkari, Omar
Krammer, Christine
Sinitski, Dzmitry
Hille, Kathleen
Zan, Chunfang
Yan, Guangyao
Wang, Sijia
Gao, Ying
Brandhofer, Markus
Megens, Remco T. A.
Hoffmann, Adrian
Pauli, Jessica http://orcid.org/0000-0001-5984-3529
Asare, Yaw http://orcid.org/0000-0002-8946-5650
Gerra, Simona
Bourilhon, Priscila http://orcid.org/0000-0002-0693-4467
Leng, Lin
Eckstein, Hans-Henning
Kempf, Wolfgang E.
Pelisek, Jaroslav
Gokce, Ozgun
Maegdefessel, Lars
Bucala, Richard
Dichgans, Martin http://orcid.org/0000-0002-0654-387X
Weber, Christian
Kapurniotu, Aphrodite http://orcid.org/0000-0001-6124-7232
Bernhagen, Jürgen http://orcid.org/0000-0003-2996-2652
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB1123/B3, SFB1123/B5, SFB1123/B3, EXC 2145 SyNergy – ID 390857198, SFB1123/A1, EXC 2145 SyNergy – ID 390857198, SFB1123/A3, INST 409/209-1 FUGG, EXC 2145 SyNergy – ID 390857198, SFB1123/A3)
U.S. Department of Health & Human Services | National Institutes of Health (NIH R01 AR049610)
Article History
Received: 2 December 2019
Accepted: 28 October 2020
First Online: 25 November 2020
Competing interests
: J.B., R.B., and C.W. are co-inventors of patents covering anti-MIF strategies (antibodies, small molecules, and MIF sequence-derived peptides) for inflammatory and cardiovascular diseases. C.Ko., A.K., O.E., and J.B. are co-inventors of a patent application covering MIF-binding CXCR4 ectodomain mimics for inflammatory and cardiovascular diseases. The remaining authors declare no competing interests.